-
Story /
-
Story /
Researchers focus on reversing the scarring that’s common to liver diseases.
-
Story /
Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.
-
Story /
A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.
-
Story /
Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.
-
Story /
A diminutive protein prompts a closer look at DNA dark matter.
-
Featured News /
European Medicines Agency (EMA) recently approved two European Novartis sites for commercial CAR-T manufacturing.
-
Featured News /
The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.
-
Story /
Novartis is taming nuclear power and putting it to use to treat advanced cancer.
-
Story /
Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.
Pagination
- ‹ Previous page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- …
- 272
- › Next page